M
Maricela Valerio
Researcher at Hospital General Universitario Gregorio Marañón
Publications - 128
Citations - 2554
Maricela Valerio is an academic researcher from Hospital General Universitario Gregorio Marañón. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 23, co-authored 101 publications receiving 1566 citations. Previous affiliations of Maricela Valerio include Complutense University of Madrid.
Papers
More filters
Journal ArticleDOI
Invasive pulmonary aspergillosis in the COVID-19 era: An expected new entity.
Marina Machado,Maricela Valerio,Ana Álvarez-Uría,Ana Álvarez-Uría,María Olmedo,Cristina Veintimilla,Belén Padilla,Sofía de la Villa,Jesús Guinea,Pilar Escribano,María Jesús Ruiz-Serrano,Elena Reigadas,Roberto Alonso,Roberto Alonso,José Eugenio Guerrero,Javier Hortal,Emilio Bouza,Patricia Muñoz +17 more
TL;DR: This work describes eight CAPA patients, compares them to colonised ICU patients with coronavirus disease 2019 (COVID‐19), and reviews the published literature from Western countries.
Journal ArticleDOI
COVID-19-Associated Pulmonary Aspergillosis, March-August 2020.
Jon Salmanton-García,Rosanne Sprute,Jannik Stemler,Michele Bartoletti,Damien Dupont,Damien Dupont,Maricela Valerio,Carolina Garcia-Vidal,Iker Falces-Romero,Marina Machado,Sofía de la Villa,Maria Schroeder,I. Hoyo,Frank Hanses,Kennio Ferreira-Paim,Daniele Roberto Giacobbe,Jacques F. Meis,Jean-Pierre Gangneux,Azucena Rodríguez-Guardado,Spinello Antinori,Ertan Sal,Xhorxha Malaj,Danila Seidel,Oliver A. Cornely,Philipp Koehler +24 more
TL;DR: Wang et al. as mentioned in this paper collected data from 186 patients who had coronavirus disease-associated pulmonary aspergillosis (CAPA) worldwide during March-August 2020, and found that the cumulative incidence of CAPA in the ICU ranged from 1.0% to 39.1%.
Journal ArticleDOI
Campylobacter bacteremia: clinical characteristics, incidence, and outcome over 23 years.
Ana Fernández-Cruz,Patricia Muñoz,Rosa Mohedano,Maricela Valerio,Mercedes Marín,Luis Alcalá,Marta Rodríguez-Créixems,Emilia Cercenado,Emilio Bouza +8 more
TL;DR: Campylobacter bacteremia is no longer a significant disease of HIV-positive patients on HAART, but often affects other immunocompromised patients as well.
Journal ArticleDOI
Dalbavancin in the treatment of different gram-positive infections: a real-life experience
Emilio Bouza,Maricela Valerio,Alex Soriano,Laura Morata,Enrique García Carus,Carmen Guadalupe Rodríguez-González,Ma Carmen Hidalgo-Tenorio,Antonio Plata,Patricia Muñoz,Antonio Vena +9 more
TL;DR: Dalbavancin appears to be an effective therapy for many serious Gram-positive infections and to reduce hospitalisation by 1160 days, with an estimated overall cost reduction of €211 481 (€3064 per patient).
Journal ArticleDOI
Evaluation of antifungal use in a tertiary care institution: antifungal stewardship urgently needed
Maricela Valerio,Carmen Guadalupe Rodríguez-González,Patricia Muñoz,Betsabe Caliz,María Sanjurjo,Emilio Bouza +5 more
TL;DR: The study demonstrated the potential cost savings that could be achieved by optimizing antifungal therapy and proposed a point score for this evaluation and to estimate the potential economic savings of an antIFungal stewardship programme.